Risk Assessment Report – 27 May 2020


Watch ASEAN Journey


 Subscribe

Risk Assessment Report – 27 May 2020


Rapid Risk Assessment

May 27, 2020

Risk Assessment Report – 27 May 2020

Time Period Covered May 27, 2020 - May 27, 2020

  • World Health Organization’s (WHO) Director-General, in his regular media briefing, mentioned that “over 400 hospitals in 35 countries are actively recruiting patients and nearly 3500 patients have been enrolled from 17 countries” as part of the Solidarity Trial which was established to evaluate the safety and efficacy of four drugs and drug combinations against COVID-19.
  • Indonesia’s National Police are tightening security at all mudik (exodus) checkpoints since Monday (May 25) to monitor post-Idul Fitri traffic. They say they will not allow people who have left Jakarta to return without an Exit and Entry Permit (SIKM). People wishing to enter Jakarta are required to obtain a permit from the Jakarta administration and the police. Any passengers who do not meet the requirements will be prevented from continuing the trip.
  • Thailand’s government extended its state of emergency until end of June as suggested by the Centre for COVID-19 Situation Administration (CCSA). According to the government spokesperson, the state of emergency is still necessary because it helps in the containment and prevention of the spread of COVID-19 and supports officials in their performance of duties, as well as their speed and continuity in helping people. As Thailand is approaching the third and fourth stages of lockdown relaxations, the spokesperson said that it is necessary that several measures remain in place and are implemented effectively to ensure that the contagion is kept under control, if not eliminated.
  • The Philippines’ Department of Health (DOH) announced on May 26 that it will stop administering hydroxychloroquine in its clinical trials on COVID-19 patients in accordance with the recommendation of the World Health Organization (WHO). The announcement was made a day after the WHO said that it is suspending the use of the anti-malaria drug due to safety reasons. Hydroxychloroquine is one of four drugs being administered in the WHO’s experimental treatments in multiple countries, called a solidarity trial, in hopes of finding a cure for COVID-19.
  • On May 25, Japan’s Prime Minister has lifted its state of emergency in the country’s last five prefectures, including Tokyo. During his press conference, he noted that the number of hospitalized COVID-19 patients has dropped from 10,000 about 1 month ago to 2000. Although the state of emergency has been lifted, there will still be an extensive and detailed governmental guidelines for different sectors of the economy